Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Cosmetic Industry News Revolution Beauty spurns private equity offer from True and explores equity raise amid deep sales slump Revolution Beauty rejects a private equity bid from True and eyes a capital raise. Learn what this means for its turnaround plan and investor sentiment. byPallavi MadhirajuAugust 11, 2025